Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

789
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
789
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

733
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
733
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.0K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.1K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of discontinuation and reduction of respiratory cotherapies on the effectiveness of CFTR modulators.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

[Adherence to chest physiotherapy in adults with cystic fibrosis].

Revue des maladies respiratoires·2024
Same author

Intravenous immunoglobulin as a rescue therapy for severe adult autoimmune hemolytic anemia: Results from a French multicenter observational study.

American journal of hematology·2024
Same author

Recurrent (or episodic) fever of unknown origin (FUO) as a variant subgroup of classical FUO: A French multicentre retrospective study of 170 patients.

Clinical medicine (London, England)·2024
Same author

Extra respiratory comorbidities in adult patients with cystic fibrosis.

European journal of internal medicine·2023
Same author

[Sarcoid uveitis: Ophthalmologist's and internist's viewpoints].

La Revue de medecine interne·2023

Related Experiment Video

Updated: Dec 17, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

908

Sarcoidosis diagnosed in the elderly: a case-control study.

A Bert1, T Gilbert2, V Cottin3

  • 1Department of Internal Medicine, University Hospital Lyon Croix-Rousse, Claude Bernard University Lyon 1, 103 Grande Rue de la Croix-Rousse, 69004 Lyon, France.

QJM : Monthly Journal of the Association of Physicians
|June 23, 2020
PubMed
Summary

Elderly-onset sarcoidosis (EOS) presents differently than young-onset sarcoidosis (YOS), with more comorbidities and uveitis. Elderly patients also experience more side effects from corticosteroid treatments.

More Related Videos

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.2K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K

Related Experiment Videos

Last Updated: Dec 17, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

908
Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.2K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K

Area of Science:

  • Pulmonology
  • Rheumatology
  • Ophthalmology

Background:

  • Sarcoidosis studies in elderly patients are limited, with no specific focus on those aged 75 and above at diagnosis.
  • This study addresses the gap in understanding sarcoidosis in the elderly population.

Purpose of the Study:

  • To analyze the distinct characteristics of sarcoidosis patients diagnosed after age 75.
  • To compare elderly-onset sarcoidosis (EOS) with young-onset sarcoidosis (YOS).

Main Methods:

  • A multicenter case-control study was conducted comparing 34 EOS patients with 102 YOS controls.
  • Data collected included demographics, medical history, clinical presentation, diagnostics, biopsies, treatments, and outcomes.

Main Results:

  • EOS patients were more frequently Caucasian and had significantly more comorbidities.
  • EOS showed less pulmonary involvement and lymphadenopathy but more uveitis compared to YOS.
  • Pathological confirmation was less frequent in EOS, and corticosteroid side effects were more common.

Conclusions:

  • The epidemiology and clinical presentation of EOS differ significantly from YOS.
  • Elderly patients with sarcoidosis exhibit a higher prevalence of comorbidities and uveitis.
  • Elderly individuals are more susceptible to adverse effects from corticosteroid therapy.